CA
Crumly & Associates’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-540
| Closed | -$273K | – | 134 |
|
|
2023
Q3 | $273K | Sell |
540
-383
| -41% | -$194K | 0.11% | 100 |
|
|
2023
Q2 | $481K | Sell |
923
-351
| -28% | -$183K | 0.19% | 75 |
|
|
2023
Q1 | $734K | Buy |
1,274
+19
| +2% | +$11K | 0.32% | 54 |
|
|
2022
Q4 | $691K | Sell |
1,255
-17
| -1% | -$9.36K | 0.26% | 47 |
|
|
2022
Q3 | $645K | Buy |
1,272
+9
| +0.7% | +$4.56K | 0.27% | 47 |
|
|
2022
Q2 | $686K | Buy |
1,263
+81
| +7% | +$44K | 0.29% | 50 |
|
|
2022
Q1 | $698K | Buy |
1,182
+13
| +1% | +$7.68K | 0.26% | 60 |
|
|
2021
Q4 | $695K | Buy |
1,169
+70
| +6% | +$41.6K | 0.27% | 57 |
|
|
2021
Q3 | $628K | Buy |
1,099
+54
| +5% | +$30.9K | 0.29% | 58 |
|
|
2021
Q2 | $527K | Buy |
1,045
+168
| +19% | +$84.7K | 0.26% | 65 |
|
|
2021
Q1 | $400K | Buy |
877
+359
| +69% | +$164K | 0.23% | 57 |
|
|
2020
Q4 | $267K | Buy |
+518
| New | +$267K | 0.19% | 60 |
|